BioSpace News Archive

BioMidwest

Express Scripts enhances strategies to support access to care at independent pharmacies

Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.

May 23, 2024
·
3 min read
Biotech Beach

Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference

Bionoxx Inc., an innovative biotech company developing neutrophil-directed T cell modulation technology, announced it will unveil its novel immunomodulatory technology at the upcoming 2024 BIO International Convention.

May 23, 2024
·
2 min read
Business

Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal

Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.

May 23, 2024
·
2 min read
BioMidwest

Gamma Biosciences Announces Sale of Mirus Bio to Merck KGaA, Darmstadt, Germany, for $600 Million

Gamma Biosciences announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt, Germany, will acquire Gamma operating company Mirus Bio for $600 million in cash.

May 23, 2024
·
4 min read
Genetown

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

Akebia Therapeutics today announced that John Butler, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 9:00 a.m. ET.

May 23, 2024
·
1 min read
Deals

Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies

Orna Therapeutics today announced its acquisition of ReNAgade Therapeutics, a pioneer in unlocking the potential of RNA therapeutics that demonstrated industry-leading delivery to multiple extra-hepatic cells in non-human primate (NHP) models over the past 18 months.

May 23, 2024
·
4 min read
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

LENSAR, Inc. today announced that Nick Curtis, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 1:40 p.m. CT in Austin, TX.

May 23, 2024
·
1 min read
Pharm Country

Establishment Labs Announces Participation in Two Upcoming Investment Conferences - May 23 2024

Establishment Labs Holdings Inc. today announced its participation in two upcoming investment conferences.

May 23, 2024
·
2 min read
Biotech Bay

Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

Radar Therapeutics today announced the completion of an oversubscribed $13.4 million in seed financing led by NfX Bio.

May 23, 2024
·
4 min read
Genetown

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.

May 23, 2024
·
1 min read